- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 8 x GLY: GLYCINE(Non-covalent)
GLY.3: 5 residues within 4Å:- Chain A: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.98
- Salt bridges: A:K.131
GLY.21: 5 residues within 4Å:- Chain B: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.98
- Salt bridges: B:K.131
GLY.39: 5 residues within 4Å:- Chain C: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:W.98
- Salt bridges: C:K.131
GLY.57: 5 residues within 4Å:- Chain D: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:W.98
- Salt bridges: D:K.131
GLY.75: 5 residues within 4Å:- Chain E: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:W.98
- Salt bridges: E:K.131
GLY.93: 5 residues within 4Å:- Chain F: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:W.98
- Salt bridges: F:K.131
GLY.111: 5 residues within 4Å:- Chain G: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:W.98
- Salt bridges: G:K.131
GLY.129: 5 residues within 4Å:- Chain H: L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:W.98
- Salt bridges: H:K.131
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: R.14, N.57
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.106, N.188, K.190
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain A: R.465, K.469, N.485
Ligand excluded by PLIPNAG.7: 1 residues within 4Å:- Chain A: N.256
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain B: R.14, N.57
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.106, N.188, K.190
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain B: R.465, K.469, N.485
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.256
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: R.14, N.57
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: N.106, N.188, K.190
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: R.465, K.469, N.485
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.256
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain D: R.14, N.57
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain D: N.106, N.188, K.190
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain D: R.465, K.469, N.485
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain D: N.256
Ligand excluded by PLIPNAG.76: 2 residues within 4Å:- Chain E: R.14, N.57
Ligand excluded by PLIPNAG.77: 3 residues within 4Å:- Chain E: N.106, N.188, K.190
Ligand excluded by PLIPNAG.78: 3 residues within 4Å:- Chain E: R.465, K.469, N.485
Ligand excluded by PLIPNAG.79: 1 residues within 4Å:- Chain E: N.256
Ligand excluded by PLIPNAG.94: 2 residues within 4Å:- Chain F: R.14, N.57
Ligand excluded by PLIPNAG.95: 3 residues within 4Å:- Chain F: N.106, N.188, K.190
Ligand excluded by PLIPNAG.96: 3 residues within 4Å:- Chain F: R.465, K.469, N.485
Ligand excluded by PLIPNAG.97: 1 residues within 4Å:- Chain F: N.256
Ligand excluded by PLIPNAG.112: 2 residues within 4Å:- Chain G: R.14, N.57
Ligand excluded by PLIPNAG.113: 3 residues within 4Å:- Chain G: N.106, N.188, K.190
Ligand excluded by PLIPNAG.114: 3 residues within 4Å:- Chain G: R.465, K.469, N.485
Ligand excluded by PLIPNAG.115: 1 residues within 4Å:- Chain G: N.256
Ligand excluded by PLIPNAG.130: 2 residues within 4Å:- Chain H: R.14, N.57
Ligand excluded by PLIPNAG.131: 3 residues within 4Å:- Chain H: N.106, N.188, K.190
Ligand excluded by PLIPNAG.132: 3 residues within 4Å:- Chain H: R.465, K.469, N.485
Ligand excluded by PLIPNAG.133: 1 residues within 4Å:- Chain H: N.256
Ligand excluded by PLIP- 40 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 1 residues within 4Å:- Chain A: R.347
Ligand excluded by PLIPCL.9: 1 residues within 4Å:- Chain A: T.512
Ligand excluded by PLIPCL.10: 1 residues within 4Å:- Chain A: R.40
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain A: P.189, F.217, T.218
Ligand excluded by PLIPCL.12: 2 residues within 4Å:- Chain A: Q.316, N.415
Ligand excluded by PLIPCL.26: 1 residues within 4Å:- Chain B: R.347
Ligand excluded by PLIPCL.27: 1 residues within 4Å:- Chain B: T.512
Ligand excluded by PLIPCL.28: 1 residues within 4Å:- Chain B: R.40
Ligand excluded by PLIPCL.29: 3 residues within 4Å:- Chain B: P.189, F.217, T.218
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain B: Q.316, N.415
Ligand excluded by PLIPCL.44: 1 residues within 4Å:- Chain C: R.347
Ligand excluded by PLIPCL.45: 1 residues within 4Å:- Chain C: T.512
Ligand excluded by PLIPCL.46: 1 residues within 4Å:- Chain C: R.40
Ligand excluded by PLIPCL.47: 3 residues within 4Å:- Chain C: P.189, F.217, T.218
Ligand excluded by PLIPCL.48: 2 residues within 4Å:- Chain C: Q.316, N.415
Ligand excluded by PLIPCL.62: 1 residues within 4Å:- Chain D: R.347
Ligand excluded by PLIPCL.63: 1 residues within 4Å:- Chain D: T.512
Ligand excluded by PLIPCL.64: 1 residues within 4Å:- Chain D: R.40
Ligand excluded by PLIPCL.65: 3 residues within 4Å:- Chain D: P.189, F.217, T.218
Ligand excluded by PLIPCL.66: 2 residues within 4Å:- Chain D: Q.316, N.415
Ligand excluded by PLIPCL.80: 1 residues within 4Å:- Chain E: R.347
Ligand excluded by PLIPCL.81: 1 residues within 4Å:- Chain E: T.512
Ligand excluded by PLIPCL.82: 1 residues within 4Å:- Chain E: R.40
Ligand excluded by PLIPCL.83: 3 residues within 4Å:- Chain E: P.189, F.217, T.218
Ligand excluded by PLIPCL.84: 2 residues within 4Å:- Chain E: Q.316, N.415
Ligand excluded by PLIPCL.98: 1 residues within 4Å:- Chain F: R.347
Ligand excluded by PLIPCL.99: 1 residues within 4Å:- Chain F: T.512
Ligand excluded by PLIPCL.100: 1 residues within 4Å:- Chain F: R.40
Ligand excluded by PLIPCL.101: 3 residues within 4Å:- Chain F: P.189, F.217, T.218
Ligand excluded by PLIPCL.102: 2 residues within 4Å:- Chain F: Q.316, N.415
Ligand excluded by PLIPCL.116: 1 residues within 4Å:- Chain G: R.347
Ligand excluded by PLIPCL.117: 1 residues within 4Å:- Chain G: T.512
Ligand excluded by PLIPCL.118: 1 residues within 4Å:- Chain G: R.40
Ligand excluded by PLIPCL.119: 3 residues within 4Å:- Chain G: P.189, F.217, T.218
Ligand excluded by PLIPCL.120: 2 residues within 4Å:- Chain G: Q.316, N.415
Ligand excluded by PLIPCL.134: 1 residues within 4Å:- Chain H: R.347
Ligand excluded by PLIPCL.135: 1 residues within 4Å:- Chain H: T.512
Ligand excluded by PLIPCL.136: 1 residues within 4Å:- Chain H: R.40
Ligand excluded by PLIPCL.137: 3 residues within 4Å:- Chain H: P.189, F.217, T.218
Ligand excluded by PLIPCL.138: 2 residues within 4Å:- Chain H: Q.316, N.415
Ligand excluded by PLIP- 8 x BR: BROMIDE ION(Non-covalent)
BR.13: 3 residues within 4Å:- Chain A: E.197, X.198
- Ligands: 15F.18
Ligand excluded by PLIPBR.31: 3 residues within 4Å:- Chain B: E.197, X.198
- Ligands: 15F.36
Ligand excluded by PLIPBR.49: 3 residues within 4Å:- Chain C: E.197, X.198
- Ligands: 15F.54
Ligand excluded by PLIPBR.67: 3 residues within 4Å:- Chain D: E.197, X.198
- Ligands: 15F.72
Ligand excluded by PLIPBR.85: 3 residues within 4Å:- Chain E: E.197, X.198
- Ligands: 15F.90
Ligand excluded by PLIPBR.103: 3 residues within 4Å:- Chain F: E.197, X.198
- Ligands: 15F.108
Ligand excluded by PLIPBR.121: 3 residues within 4Å:- Chain G: E.197, X.198
- Ligands: 15F.126
Ligand excluded by PLIPBR.139: 3 residues within 4Å:- Chain H: E.197, X.198
- Ligands: 15F.144
Ligand excluded by PLIP- 16 x CA: CALCIUM ION(Non-covalent)
CA.14: 2 residues within 4Å:- Chain A: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.15: 3 residues within 4Å:- Chain A: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.32: 2 residues within 4Å:- Chain B: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.33: 3 residues within 4Å:- Chain B: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.50: 2 residues within 4Å:- Chain C: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.51: 3 residues within 4Å:- Chain C: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.68: 2 residues within 4Å:- Chain D: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.69: 3 residues within 4Å:- Chain D: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.86: 2 residues within 4Å:- Chain E: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.87: 3 residues within 4Å:- Chain E: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.104: 2 residues within 4Å:- Chain F: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.105: 3 residues within 4Å:- Chain F: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.122: 2 residues within 4Å:- Chain G: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.123: 3 residues within 4Å:- Chain G: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)CA.140: 2 residues within 4Å:- Chain H: Y.420, R.515
No protein-ligand interaction detected (PLIP)CA.141: 3 residues within 4Å:- Chain H: S.487, T.488, T.508
No protein-ligand interaction detected (PLIP)- 16 x NA: SODIUM ION(Non-functional Binders)
NA.16: 1 residues within 4Å:- Chain A: R.242
Ligand excluded by PLIPNA.17: 2 residues within 4Å:- Chain A: C.66, Q.270
Ligand excluded by PLIPNA.34: 1 residues within 4Å:- Chain B: R.242
Ligand excluded by PLIPNA.35: 2 residues within 4Å:- Chain B: C.66, Q.270
Ligand excluded by PLIPNA.52: 1 residues within 4Å:- Chain C: R.242
Ligand excluded by PLIPNA.53: 2 residues within 4Å:- Chain C: C.66, Q.270
Ligand excluded by PLIPNA.70: 1 residues within 4Å:- Chain D: R.242
Ligand excluded by PLIPNA.71: 2 residues within 4Å:- Chain D: C.66, Q.270
Ligand excluded by PLIPNA.88: 1 residues within 4Å:- Chain E: R.242
Ligand excluded by PLIPNA.89: 2 residues within 4Å:- Chain E: C.66, Q.270
Ligand excluded by PLIPNA.106: 1 residues within 4Å:- Chain F: R.242
Ligand excluded by PLIPNA.107: 2 residues within 4Å:- Chain F: C.66, Q.270
Ligand excluded by PLIPNA.124: 1 residues within 4Å:- Chain G: R.242
Ligand excluded by PLIPNA.125: 2 residues within 4Å:- Chain G: C.66, Q.270
Ligand excluded by PLIPNA.142: 1 residues within 4Å:- Chain H: R.242
Ligand excluded by PLIPNA.143: 2 residues within 4Å:- Chain H: C.66, Q.270
Ligand excluded by PLIP- 8 x 15F: 1-BENZYL-4-({[(1E)-2,2,2-TRICHLOROETHANIMIDOYL]OXY}METHYL)PYRIDINIUM(Non-covalent)
15F.18: 14 residues within 4Å:- Chain A: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.13
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:A.328, A:F.329, A:W.430, A:Y.440
- pi-Stacking: A:W.82, A:Y.332
- Halogen bonds: A:S.287
15F.36: 14 residues within 4Å:- Chain B: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.31
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:A.328, B:F.329, B:W.430, B:Y.440
- pi-Stacking: B:W.82, B:Y.332
- Halogen bonds: B:S.287
15F.54: 14 residues within 4Å:- Chain C: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.49
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:A.328, C:F.329, C:W.430, C:Y.440
- pi-Stacking: C:W.82, C:Y.332
- Halogen bonds: C:S.287
15F.72: 14 residues within 4Å:- Chain D: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.67
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:A.328, D:F.329, D:W.430, D:Y.440
- pi-Stacking: D:W.82, D:Y.332
- Halogen bonds: D:S.287
15F.90: 14 residues within 4Å:- Chain E: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.85
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:A.328, E:F.329, E:W.430, E:Y.440
- pi-Stacking: E:W.82, E:Y.332
- Halogen bonds: E:S.287
15F.108: 14 residues within 4Å:- Chain F: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.103
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:A.328, F:F.329, F:W.430, F:Y.440
- pi-Stacking: F:W.82, F:Y.332
- Halogen bonds: F:S.287
15F.126: 14 residues within 4Å:- Chain G: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.121
7 PLIP interactions:7 interactions with chain G- Hydrophobic interactions: G:A.328, G:F.329, G:W.430, G:Y.440
- pi-Stacking: G:W.82, G:Y.332
- Halogen bonds: G:S.287
15F.144: 14 residues within 4Å:- Chain H: D.70, W.82, G.116, G.117, P.285, L.286, S.287, A.328, F.329, W.430, M.437, H.438, Y.440
- Ligands: BR.139
7 PLIP interactions:7 interactions with chain H- Hydrophobic interactions: H:A.328, H:F.329, H:W.430, H:Y.440
- pi-Stacking: H:W.82, H:Y.332
- Halogen bonds: H:S.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., A Step Toward the Reactivation of Aged Cholinesterases -Crystal Structure of Ligands Binding to Aged Human Butyrylcholinesterase. Chem.Biol.Interact (2013)
- Release Date
- 2012-08-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 8 x GLY: GLYCINE(Non-covalent)
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x CL: CHLORIDE ION(Non-functional Binders)
- 8 x BR: BROMIDE ION(Non-covalent)
- 16 x CA: CALCIUM ION(Non-covalent)
- 16 x NA: SODIUM ION(Non-functional Binders)
- 8 x 15F: 1-BENZYL-4-({[(1E)-2,2,2-TRICHLOROETHANIMIDOYL]OXY}METHYL)PYRIDINIUM(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., A Step Toward the Reactivation of Aged Cholinesterases -Crystal Structure of Ligands Binding to Aged Human Butyrylcholinesterase. Chem.Biol.Interact (2013)
- Release Date
- 2012-08-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A